Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?
- 23 September 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer and Metastasis Reviews
- Vol. 25 (3), 333-356
- https://doi.org/10.1007/s10555-006-9010-6
Abstract
The tumor microenvironment consists of a variable combination of tumor cells, stromal fibroblasts, endothelial cells and infiltrating leukocytes, such as macrophages, T lymphocytes, and dendritic cells. A variety of cytokines, chemokines and growth factors are produced in the local tumor environment by different cells accounting for a complex cell interaction and regulation of differentiation, activation, function and survival of multiple cell types. The interaction between cytokines, chemokines, growth factors and their receptors forms a comprehensive network at the tumor site, which is primary responsible for overall tumor progression and spreading or induction of antitumor immune responses and tumor rejection. Although the general thought is that dendritic cells are among the first cells migrating to the tumor site and recognizing tumor cells for the induction of specific antitumor immunity, the clinical relevance of dendritic cells at the site of the tumor remains a matter of debate regarding their role in the generation of successful antitumor immune responses in human cancers. While several lines of evidence suggest that intratumoral dendritic cells play an important role in antitumor immune responses, understanding the mechanisms of dendritic cell/tumor cell interaction and modulation of activity and function of different dendritic cell subtypes at the tumor site is incomplete. This review is limited to discussing the role of intratumoral cytokine network in the understanding immunobiology of tumor-associated dendritic cells, which seems to possess different regulatory functions at the tumor site.Keywords
This publication has 206 references indexed in Scilit:
- Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce “danger signals”Breast Cancer Research and Treatment, 2005
- Functions and regulation of transforming growth factor-beta (TGF-β) in the prostateEuropean Journal Of Cancer, 2005
- Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8International Journal of Cancer, 2005
- Impaired function of circulating dendritic cells in patients with pancreatic cancerClinical Immunology, 2004
- Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progressionEuropean Journal Of Cancer, 2004
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Regulation of dendropoiesis in cancerClinical Immunology Newsletter, 1999
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Constitutive secretion of bioactive transforming growth factor β1 by small cell lung cancer cell linesEuropean Journal Of Cancer, 1994
- Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: In vitro restoration of this immunosuppression by thymic hormonesCancer Immunology, Immunotherapy, 1993